Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Liquidia Corp
(NQ:
LQDA
)
9.970
+0.340 (+3.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Liquidia Corp
< Previous
1
2
3
4
5
6
7
Next >
LQDA Stock Earnings: Liquidia Misses EPS, Misses Revenue for Q1 2024
May 14, 2024
LQDA stock results show that Liquidia missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 13, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD
May 10, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Present at BofA Securities Health Care Conference 2024
May 07, 2024
From
Liquidia Corporation
Via
GlobeNewswire
The Analyst Landscape: 5 Takes On Liquidia
April 01, 2024
Via
Benzinga
Unveiling 6 Analyst Insights On Liquidia
March 13, 2024
Via
Benzinga
Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024
May 07, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Jim Cramer: You're 'Dice Rolling' With This Biopharma Stock, But Vista Energy Is 'A Good Situation'
April 25, 2024
"Mad Money Lightning Round," Jim Cramer recommended buying Cloudflare. "I would buy it slowly because we've got big selling going on in AI stock Meta," he added.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
April 01, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Recap: iShares $ Corp Bond UCITS ETF Q4 Earnings
March 13, 2024
Via
Benzinga
Topics
ETFs
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 27, 2024
Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 18, 2024
Via
Benzinga
Build-A-Bear Workshop Reports Upbeat Earnings, Joins VAALCO Energy, Dick's Sporting Goods And Other Big Stocks Moving Higher On Thursday
March 14, 2024
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Liquidia Earnings Preview
March 12, 2024
Via
Benzinga
Decoding 5 Analyst Evaluations For Liquidia
January 05, 2024
Via
Benzinga
Earnings Scheduled For March 13, 2024
March 13, 2024
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
Via
Benzinga
Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update
March 13, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024
March 06, 2024
From
Liquidia Corporation
Via
GlobeNewswire
United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings
February 21, 2024
Legal battle unfolds as United Therapeutics challenges FDA's handling of Liquidia's drug approval process. Explore the implications on PH-ILD, potential 30-month stay, and recent financial...
Via
Benzinga
Exposures
Product Safety
This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate
February 12, 2024
United Therapeutics Corporation (NASDAQ: UTHR) is in a patent dispute with Liquidia Corp (NASDAQ:
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress
January 30, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder
January 25, 2024
From
Liquidia Corporation
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
January 23, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 22, 2024
Via
Benzinga
Liquidia Corporation Announces Updates to Operations Leadership
January 19, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 17, 2024
Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announced a partnership with GCT Semiconductor to develop an RF module. Airspan...
Via
Benzinga
Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims
January 08, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD
January 05, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation Announces $100 Million in New Financings
January 04, 2024
From
Liquidia Corporation
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.